Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
Lancet (London, England)
|
June 29, 2024
Targeted release of budesonide in primary IgA nephropathy
Yitong Hu, Yuemiao Zhang
Nephrology (Carlton, Vic.)
|
July 3, 2024
Current understanding and new insights in the treatment of IgA nephropathy
Yuemiao Zhang, Hong Zhang
Glomerular Diseases
|
February 8, 2023
IgA Nephropathy: A Chinese Perspective
Zhao Zhang, Yuemiao Zhang, Hong Zhang
Cardiorenal Medicine
|
May 11, 2025
The Cardiac and Renal Safety of Semaglutide in Patients with Type 2 Diabetes: A Real-World Study Based on FAERS
Jingyu Wang, Tong Xie, Yuemiao Zhang, et al.
Autoimmunity Reviews
|
May 13, 2025
New thoughts on the intestinal microbiome-B cell-IgA axis and therapies in IgA nephropathy
Shaoqing Dang, Xiangyu Zhang, Yuemiao Zhang, et al.
Renal Failure
|
February 12, 2024
Current perspectives and trends of the research on hypertensive nephropathy: a bibliometric analysis from 2000 to 2023
Lan Wang, Jingyu Wang, Yuemiao Zhang, et al.
Health Data Science
|
September 4, 2025
Characterizing the Real-World Risks of Kidney Injuries Associated with Chimeric Antigen Receptor T Cell Therapies-Evidence and Safety
Jingyu Wang, Tong Xie, Jiawen Peng, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
June 8, 2025
Role of Chimeric Antigen Receptor-Expressing Cell Therapy in Immune-Mediated Kidney Diseases: A Review
Jiawen Peng, Yuemiao Zhang, Jingyu Wang, et al.
Helicobacter
|
May 23, 2014
Tetracycline- and furazolidone-containing quadruple regimen as rescue treatment for Helicobacter pylori infection: a single center retrospective study
Yuemiao Zhang, Wen Gao, Hong Cheng, et al.
Pediatric Nephrology (Berlin, Germany)
|
March 7, 2023
Corticosteroids in the treatment of IgA nephropathy: lessons from the TESTING trial
Yuemiao Zhang, Yi-Tong Hu, Ji-Cheng Lv, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
Lancet (London, England)
|
June 29, 2024
Targeted release of budesonide in primary IgA nephropathy
Yitong Hu, Yuemiao Zhang
Nephrology (Carlton, Vic.)
|
July 3, 2024
Current understanding and new insights in the treatment of IgA nephropathy
Yuemiao Zhang, Hong Zhang
Glomerular Diseases
|
February 8, 2023
IgA Nephropathy: A Chinese Perspective
Zhao Zhang, Yuemiao Zhang, Hong Zhang
Cardiorenal Medicine
|
May 11, 2025
The Cardiac and Renal Safety of Semaglutide in Patients with Type 2 Diabetes: A Real-World Study Based on FAERS
Jingyu Wang, Tong Xie, Yuemiao Zhang, et al.
Autoimmunity Reviews
|
May 13, 2025
New thoughts on the intestinal microbiome-B cell-IgA axis and therapies in IgA nephropathy
Shaoqing Dang, Xiangyu Zhang, Yuemiao Zhang, et al.
Renal Failure
|
February 12, 2024
Current perspectives and trends of the research on hypertensive nephropathy: a bibliometric analysis from 2000 to 2023
Lan Wang, Jingyu Wang, Yuemiao Zhang, et al.
Health Data Science
|
September 4, 2025
Characterizing the Real-World Risks of Kidney Injuries Associated with Chimeric Antigen Receptor T Cell Therapies-Evidence and Safety
Jingyu Wang, Tong Xie, Jiawen Peng, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
June 8, 2025
Role of Chimeric Antigen Receptor-Expressing Cell Therapy in Immune-Mediated Kidney Diseases: A Review
Jiawen Peng, Yuemiao Zhang, Jingyu Wang, et al.
Helicobacter
|
May 23, 2014
Tetracycline- and furazolidone-containing quadruple regimen as rescue treatment for Helicobacter pylori infection: a single center retrospective study
Yuemiao Zhang, Wen Gao, Hong Cheng, et al.
Pediatric Nephrology (Berlin, Germany)
|
March 7, 2023
Corticosteroids in the treatment of IgA nephropathy: lessons from the TESTING trial
Yuemiao Zhang, Yi-Tong Hu, Ji-Cheng Lv, et al.
Page
of 3